Pushing T cells down “memory lane” may improve cancer therapy

Scientists at St. Jude Children’s Research Hospital identified proteins that help decide T cell fate and used the finding to improve CAR-T cell therapy in a solid tumor model.
22-Jun-2022 11:00 AM EDT Add to Favorites

Research reveals high-risk subtype of relapsed pediatric AML

Scientists at St. Jude Children’s Research Hospital have found a previously overlooked mutation in a subtype of pediatric leukemia that has implications for identifying high-risk patients.
16-Feb-2022 10:00 AM EST Add to Favorites

Research Lays a Foundation for Prevention of the Most Common Childhood Cancer

Scientists at St. Jude Children’s Research Hospital and the Cancer Research Center in Spain blocked development of acute lymphoblastic leukemia in mice with a genetic mutation that increases the risk of childhood cancer.
7-Feb-2022 12:05 PM EST Add to Favorites

St. Jude Children’s Research Hospital celebrates 60 years of saving children’s lives

Diamond jubilee events planned nationwide for supporters to honor St. Jude visionaries, recognize expanding global impact of scientific, medical achievements.
4-Feb-2022 1:45 PM EST Add to Favorites

Modular super-enhancer controls retinal development

Scientists at St. Jude Children’s Research Hospital identified distinct functions for regions of a super-enhancer that controls gene expression during retina formation, calling it a ‘modular’ super-enhancer.
10-Jan-2022 12:25 PM EST Add to Favorites

VIDEO

World Health Organization and St. Jude Children’s Research Hospital to dramatically increase global access to childhood cancer medicines

The Global Platform for Access to Childhood Cancer Medicines, the first of its kind, will provide an uninterrupted supply of quality-assured childhood cancer medicines to low- and middle-income countries. St. Jude is making a six-year, $200 million...
13-Dec-2021 8:45 AM EST Add to Favorites

Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients

St. Jude Children’s Research Hospital phase II clinical trial results suggest that the monoclonal antibody hu14.18K322A could help change treatment of children with high-risk neuroblastoma.
3-Dec-2021 2:10 PM EST Add to Favorites

St. Jude researchers are again among the world’s most highly cited scientists

The thirteen scientists were named to the 2021 list of Highly Cited Researchers by the Institute for Scientific Information at Clarivate, reflecting the international reach of St. Jude research.
16-Nov-2021 9:55 AM EST Add to Favorites